| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Axsome Therapeutics, Inc. (AXSM) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. AXSM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 57.5K | $13.36M | - | |
| Dir | 48.2K | $11.20M | - | |
| CEO | 24.1K | $5.59M | - | |
| COO | 8.7K | $2.01M | - | |
| CFO | 8.2K | $1.90M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22, 2026 | Maizel Ari | Chief Commercial Officer | Sale+OE | 7,500 | $182.42 | $1,368,150.00 | -100% | - | - | |
| Feb 2, 2026 | Tabuteau Herriot45 | Chief Executive Officer | Sale+OE | 32,410 | $185.60 | $6,015,296.00 | -81.8% | +11.1% | - | |
| Jan 7, 2026 | Tabuteau Herriot45 | Chief Executive Officer | Sale+OE | 139,414 | $171.30 | $23,881,617.52 | -86.5% | -1.1% | - | |
| Dec 31, 2025 | Saad Mark E50 | Director | Sale+OE | 37,577 | $165.18 | $6,206,968.86 | -65.3% | -7.5% | - | |
| Dec 4, 2025 | Tabuteau Herriot45 | Chief Executive Officer | Sale+OE | 79,973 | $145.66 | $11,648,582.34 | -78.7% | +10.8% | - | |
| Nov 5, 2025 | Tabuteau Herriot45 | Chief Executive Officer | Sale+OE | 163,939 | $133.07 | $21,815,669.06 | -88.3% | +38.1% | - | |
| Oct 8, 2025 | Tabuteau Herriot45 | Chief Executive Officer | Sale+OE | 45,384 | $119.38 | $5,418,059.86 | -67.7% | +44.8% | - | |
| Sep 22, 2025 | Jacobson Mark L. | Chief Operating Officer | Sale+OE | 10,000 | $115.96 | $1,159,600.00 | -100% | +31.7% | - | |
| Sep 16, 2025 | Jacobson Mark L. | Chief Operating Officer | Sale+OE | 45,783 | $114.48 | $5,241,126.77 | -100% | +28.2% | - | |
| Sep 16, 2025 | Tabuteau Herriot45 | Chief Executive Officer | Sale+OE | 62,880 | $117.08 | $7,361,891.31 | -74.4% | +28.2% | - |